Article Details
Retrieved on: 2018-05-21 23:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Bridgewater Associates</b> LP purchased a new position in shares of BioMarin Pharmaceutical during the third quarter worth approximately $826,000.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here